GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

CLB073   Click here for help

GtoPdb Ligand ID: 13980

Synonyms: mCLB073 | TBD11
Compound class: Synthetic organic
Comment: CLB073 is an agonist of the Mycobacterium tuberculosis adenylyl cyclase Rv1625c [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 0
Rotatable bonds 5
Topological polar surface area 82.22
Molecular weight 421.28
XLogP 1.36
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN1C(=NC=N1)CC(=O)N2CCC(CC2)C3=NC(=NO3)C4=CC=C(C(=C4)Cl)Cl
Isomeric SMILES CN1C(=NC=N1)CC(=O)N2CCC(CC2)C3=NC(=NO3)C4=CC=C(C(=C4)Cl)Cl
InChI InChI=1S/C18H18Cl2N6O2/c1-25-15(21-10-22-25)9-16(27)26-6-4-11(5-7-26)18-23-17(24-28-18)12-2-3-13(19)14(20)8-12/h2-3,8,10-11H,4-7,9H2,1H3
InChI Key UKPJLECHPQZQLZ-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
Phase 1 trial is recruiting.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT06707142 A Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11 Phase 1 Interventional Bill & Melinda Gates Medical Research Institute